Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  2-Chloro-3-fluoropyridine-4-carboxylic acid

2-Chloro-3-fluoropyridine-4-carboxylic acid

Basic information Safety Supplier Related

2-Chloro-3-fluoropyridine-4-carboxylic acid Basic information

Product Name:
2-Chloro-3-fluoropyridine-4-carboxylic acid
Synonyms:
  • 2-CHLORO-3-FLUOROISONICOTINIC ACID
  • 2-CHLORO-3-FLUOROPYRIDINE-4-CARBOXYLIC ACID
  • 2-Chloro-3-fluoropyridine-4-carboxylic acid, 4-Carboxy-2-chloro-3-fluoropyridine
  • 2-Chloro-3-Fluoroisonicotinic Acid(WX614144)
  • 2-chloro-3-fluoro-4-pyridinecarboxylic acid
  • 4-Pyridinecarboxylic acid, 2-chloro-3-fluoro-
  • 2-Chloro-3-FluoroisonicotinicAci
  • 2-CHLORO-3-FLUOROISONICOTINIC ACID ISO 9001:2015 REACH
CAS:
628691-93-0
MF:
C6H3ClFNO2
MW:
175.54
EINECS:
672-530-6
Product Categories:
  • Building Blocks
  • C5 to C6
  • C6 to C7
  • Chemical Synthesis
  • Fluorinated Building Blocks
  • Halogenated Heterocycles
  • Heterocyclic Building Blocks
  • Heterocyclic Fluorinated Building Blocks
  • Other Fluorinated Heterocycles
  • Pyridines
  • Boronic Acid
Mol File:
628691-93-0.mol
More
Less

2-Chloro-3-fluoropyridine-4-carboxylic acid Chemical Properties

Melting point:
199 °C (dec.)
Boiling point:
389.1±37.0 °C(Predicted)
Density 
1.576±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
pka
2.07±0.10(Predicted)
form 
powder
color 
Off-white
InChI
InChI=1S/C6H3ClFNO2/c7-5-4(8)3(6(10)11)1-2-9-5/h1-2H,(H,10,11)
InChIKey
NWNWBLRKHOVSEL-UHFFFAOYSA-N
SMILES
C1(Cl)=NC=CC(C(O)=O)=C1F
CAS DataBase Reference
628691-93-0(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
HazardClass 
IRRITANT
HS Code 
2933399990

MSDS

More
Less

2-Chloro-3-fluoropyridine-4-carboxylic acid Usage And Synthesis

Uses

2-Chloro-3-fluoropyridine-4-carboxylic acid is a carboxylic acid, which has been reported in the literature to be used in the preparation of antiplatelet drugs of the ADP receptor antagonist class.

Synthesis

17282-04-1

124-38-9

628691-93-0

1. In a dry reaction flask, lithium diisopropylamide (2M in heptane/tetrahydrofuran/ethylbenzene, 16.7 ml) was mixed with tetrahydrofuran (30 ml) and cooled to -78 °C. 2. A solution of 2-chloro-3-fluoropyridine (4.0 g, 30.4 mmol) in tetrahydrofuran (30 ml) pre-cooled to -78°C was added dropwise to the above cooled mixture over a period of 20 min. 3. After 3 hours of reaction, carbon dioxide was bubbled into the cold reaction mixture for 20 minutes. 4. The reaction mixture was gradually heated to -30 °C for 1 h and then continued to 0 °C. The reaction mixture was heated to -30 °C for 1 h and then continued to 0 °C. 5. The reaction was quenched by addition of water (75 ml) and the aqueous phase was washed with ether (100 ml). 6. The pH of the aqueous phase was adjusted to 2 with 2N hydrochloric acid to produce a white precipitate, which was aged for 18 h. The mixture was filtered and air-dried to give 2-chloro-3-fluoroisonicotinic acid (4.22 g, 79%). 7. 2-Chloro-3-fluoroisonicotinic acid (3.30 g, 18.8 mmol) was suspended in thionyl chloride (40 ml) and heated to reflux for 2.5 hours. 8. The solvent was evaporated and the residue was azeotropically dried with toluene (100 ml) to give a light yellow oil. 9. The oily substance was dissolved in dichloromethane (20 ml), cooled to 0 °C and methanol (2.42 g, 75.3 mmol) was added dropwise over 15 min. 10. After the dropwise addition, the mixture was warmed to room temperature and stirred for 18 hours. 11. The solvent was evaporated and the mixture was partitioned between water (75 ml) and dichloromethane (100 ml). 12. The aqueous phase was further extracted with dichloromethane (100 ml), the organic layers were combined, washed with brine (75 ml), dried over anhydrous sodium sulfate, filtered and evaporated to give methyl 2-chloro-3-fluoroisonicotinate (3.32 g, 93%). 13. 2-Chloro-3-fluoroisonicotinic acid methyl ester (3.32 g, 17.5 mmol) was converted to 8-fluoroimidazo[1,2-a]pyridine-7-carboxylic acid methyl ester (1.4 g, 41%). 14. 8-Fluoroimidazo[1,2-a]pyridine-7-carboxylic acid methyl ester (0.19 g, 1.0 mmol) was brominated to give methyl 3-bromo-8-fluoroimidazo[1,2-a]pyridine-7-carboxylate (195 mg, 71%). 15. 3-Bromo-8-fluoroimidazo[1,2-a]pyridine-7-carboxylic acid methyl ester (0.10 g, 0.37 mmol) was coupled with 4,2'-difluoro-5'-(5,5-dimethyl[1,3,2]dioxaborolan-2-yl)biphenyl-2-ylcarbonitrile (0.15 g, 0.44 mmol) to give 3-(2'-cyano-2,4'-difluoro-biphenyl- 5-yl)-8-fluoroimidazo[1,2-a]pyridine-7-carboxylic acid methyl ester (79 mg, 53%).

References

[1] Patent: WO2003/99816, 2003, A1. Location in patent: Page 61
[2] Patent: WO2011/37771, 2011, A1. Location in patent: Page/Page column 24-25

2-Chloro-3-fluoropyridine-4-carboxylic acid Preparation Products And Raw materials

Raw materials

2-Chloro-3-fluoropyridine-4-carboxylic acidSupplier

Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. Gold
Tel
025-66028182 18626450290
Email
yftan@aikonchem.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
INTATRADE GmbH
Tel
+49 3493/605464
Email
sales@intatrade.de
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com